GM2-gangliosidosis, AB variant
General Information (adopted from Orphanet):
Synonyms, Signs: |
TAY-SACHS DISEASE, AB VARIANT AB VARIANT GM2-GANGLIOSIDOSIS GM2 ACTIVATOR DEFICIENCY hexosaminidase activator deficiency |
Number of Symptoms | 21 |
OrphanetNr: | 309246 |
OMIM Id: |
272750
|
ICD-10: |
E75.0 |
UMLs: |
|
MeSH: |
|
MedDRA: |
|
Snomed: |
|
Prevalence, inheritance and age of onset:
Prevalence: | No data available. |
Inheritance: |
Autosomal recessive inheritance [Omim] |
Age of onset: |
|
Disease classification (adopted from Orphanet):
Parent Diseases: |
GM2 gangliosidosis
-Rare genetic disease -Rare neurologic disease |
Symptom Information:
|
(HPO:0000618) | Blindness | 124 / 7739 | ||||
|
(HPO:0000741) | Apathy | 42 / 7739 | ||||
|
(HPO:0003470) | Paralysis | 11 / 7739 | ||||
|
(HPO:0001263) | Global developmental delay | 853 / 7739 | ||||
|
(HPO:0001276) | Hypertonia | 317 / 7739 | ||||
|
(HPO:0002267) | Exaggerated startle response | 42 / 7739 | ||||
|
(HPO:0000726) | Dementia | 131 / 7739 | ||||
|
(HPO:0001250) | Seizures | 1245 / 7739 | ||||
|
(HPO:0003495) | GM2-ganglioside accumulation | 2 / 7739 | ||||
|
(HPO:0002835) | Aspiration | 11 / 7739 | ||||
|
(HPO:0001252) | Muscular hypotonia | 990 / 7739 | ||||
|
(HPO:0002421) | Poor head control | 23 / 7739 | ||||
|
(HPO:0001324) | Muscle weakness | 859 / 7739 | ||||
|
(HPO:0008947) | Infantile muscular hypotonia | 482 / 7739 | ||||
|
(HPO:0010547) | Muscle flaccidity | 466 / 7739 | ||||
|
(OMIM) | Gray-white area around the retinal fovea | 1 / 7739 | ||||
|
(OMIM) | Cherry red macula | 1 / 7739 | ||||
|
(OMIM) | Both Hexosaminidase-A and B present | 1 / 7739 | ||||
|
(OMIM) | Hypertonia late | 3 / 7739 | ||||
|
(HPO:0000007) | Autosomal recessive inheritance | 2538 / 7739 | ||||
|
(OMIM) | Hex-A activating factor defect | 1 / 7739 |
Associated genes:
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|
Additional Information:
Description: (OMIM) |
The GM2-gangliosidoses are a group of disorders caused by excessive accumulation of ganglioside GM2 and related glycolipids in the lysosomes, mainly of neuronal cells. GM2-gangliosidosis AB variant is characterized by normal hexosaminidase A (HEXA; 606869) and hexosaminidase B ... |
Clinical Description OMIM |
Sandhoff et al. (1971) referred to Sandhoff disease (268800) as variant 0 (since both hexosaminidases A and B are missing) and classic Tay-Sachs disease as variant B (since HEXA is absent but HEXB is present in increased amounts). ... |
Molecular genetics OMIM |
By RT-PCR of the GM2A gene in a patient with deficiency of GM2-activator protein, Chen et al. (1999) detected some normal-sized cDNA and a smaller cDNA species, which was not seen in the RT-PCR products from normal controls. ... |